|
Market Closed -
Xetra
11:35:45 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 52.45 EUR | +3.92% |
|
+3.92% | - |
| 08-13 | Zealand Pharma sells rusfertide rights for $100m | FW |
| 08-13 | Zealand Pharma to Sell Rusfertide-linked Economics to Royalty Pharma for $100 Million | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROYALTY PHARMA PLC | Other Pharmaceuticals | +3.92% | +3.92% | - | - | - | 27.3B |
-
|
-
|
-
|
- Stock Market
- Stocks
- RPRX Stock
- RPD Stock
- Charts Royalty Pharma plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
